Simvastatin Inhibits NLRP3 Inflammasome Activation and Ameliorates Lung Injury in Hyperoxia‐Induced Bronchopulmonary Dysplasia via the KLF2‐Mediated Mechanism
Open Access
- 1 January 2022
- journal article
- research article
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2022 (1) , 8336070
Abstract
Bronchopulmonary dysplasia (BPD) is a chronic lung disease commonly found in premature infants. Excessive inflammation and oxidative stress contribute to BPD occurrence and development. Simvastatin, as an inhibitor of HMG‐CoA reductase, has been reported to have antioxidative and anti‐inflammatory effects. However, its effect and possible mechanisms in hyperoxia‐induced lung injury are rarely reported. In this study, in vivo and in vitro experiments were conducted to investigate whether simvastatin could ameliorate hyperoxia‐induced lung injury and explore its potential mechanism. For the in vivo study, simvastatin could improve alveolar development after hyperoxic lung injury and reduce hyperoxic stress and inflammation. The in vitro study revealed that simvastatin can reduce inflammation in A549 cells after high‐oxygen exposure. Simvastatin suppressed NLRP3 inflammasome activation and played anti‐inflammatory and antioxidant roles by increasing KLF2 (Krüppel‐like factor 2) expression. In vitro experiments also revealed that these effects of simvastatin were partially reversed by KLF2 shRNA, indicating that KLF2 was involved in simvastatin effects. In summary, our findings indicate that simvastatin could downregulate NLRP3 inflammasome activation and attenuate lung injury in hyperoxia‐induced bronchopulmonary dysplasia via KLF2‐mediated mechanism.Keywords
Funding Information
- Wenzhou Municipal Science and Technology Bureau (Y20180006, Y20180092)
This publication has 60 references indexed in Scilit:
- The Krüppel-like factor 2 and Krüppel-like factor 4 genes interact to maintain endothelial integrity in mouse embryonic vasculogenesisBMC Developmental Biology, 2013
- Donor Simvastatin Treatment Prevents Ischemia-Reperfusion and Acute Kidney Injury by Preserving Microvascular Barrier FunctionAmerican Journal of Transplantation, 2013
- Frontiers in pulmonary hypertension in infants and children with bronchopulmonary dysplasiaPediatric Pulmonology, 2012
- Simvastatin in the treatment of asthma: lack of steroid-sparing effectThorax, 2010
- Effects of pravastatin on functional capacity in patients with chronic obstructive pulmonary disease and pulmonary hypertensionClinical Science, 2009
- Endothelial cell barrier protection by simvastatin: GTPase regulation and NADPH oxidase inhibitionAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Abrogation of Anti-Inflammatory Transcription Factor LKLF in Neutrophil-Dominated AirwaysAmerican Journal of Respiratory Cell and Molecular Biology, 2008
- Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthmaThorax, 2008
- Krüppel-like transcription factors: A functional familyThe International Journal of Biochemistry & Cell Biology, 2008
- Cdh1-APC Controls Axonal Growth and Patterning in the Mammalian BrainScience, 2004